Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vacher

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
British Journal of Cancer|May 5, 2017
Clinical value of R-spondins in triple-negative and metaplastic breast cancersF Coussy, F Lallemand, S Vacher, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2008
Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology GroupP N Span, A M Sieuwerts, J J T M Heuvel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survivalC Dubot, V Bernard, M P Sablin, et al.
Journal of Hematology & Oncology|February 24, 2020
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancersF Coussy, R El Botty, M Lavigne, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
Oncogene|November 28, 2018
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumorsG Vargas, M Bouchet, L Bouazza, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
British Journal of Cancer|May 5, 2017
Clinical value of R-spondins in triple-negative and metaplastic breast cancersF Coussy, F Lallemand, S Vacher, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2008
Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology GroupP N Span, A M Sieuwerts, J J T M Heuvel, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2018
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survivalC Dubot, V Bernard, M P Sablin, et al.
Journal of Hematology & Oncology|February 24, 2020
Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancersF Coussy, R El Botty, M Lavigne, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2019
Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular TargetsA Moreira, J Masliah-Planchon, C Callens, et al.
Oncogene|November 28, 2018
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumorsG Vargas, M Bouchet, L Bouazza, et al.
ESMO Open|June 12, 2021
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgeryA Moreira, A Poulet, J Masliah-Planchon, et al.
Pageof 5